Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone
Rattachement africain : es. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
RATIONALE: Primary lymphomas of the uterine cervix are a rare disease. They are often misdiagnosed because of their rarity and because they can be easily confused with a squamous cell carcinoma of the cervix, as they are usually presented as exophytic mass with vaginal bleeding as their most common symptoms. Nevertheless, considering that both the prognosis and the treatment are completely different between them, differential diagnosis should be taken into account. PATIENT CONCERNS: A case of a 51-year-old woman with a primary diffuse large B-cell lymphoma of the cervix is presented. DIAGNOSES: Diagnosis of this tumor was a challenge for pathologists and clinicians, as four biopsies were needed to achieve a final diagnosis. INTERVENTIONS: Patient was successfully treated with combined Rituximab and chemotherapy (R-CHOP) alone. OUTCOMES: Complete remission, confirmed through biopsy, was reached after six courses of chemotherapy. At 2-years follow up, patient is alive and free of disease. LESSONS: Considering that the prognosis and treatment of primary malignant lymphoma of the cervix are completely different than that of the squamous cell carcinoma, awareness of this disease should be considered in the differential diagnosis.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone
- Date Crossref
- 01/05/2017
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Universidad de Salamanca pays non établi dans la noticeUniversité ou école supérieure
-
Instituto de Investigación Biomédica de Salamanca pays non établi dans la noticeStructure de recherche
-
Centro de Investigación del Cáncer pays non établi dans la noticeStructure de recherche
-
Centro de Investigación Biomédica en Red de Cáncer pays non établi dans la noticeStructure de recherche
-
Department of Obstetrics and Gynecology Department of Pathology Department of Radiology Department of Hematology University Hospital of Salamanca (IBSAL-HUS) CIBERONC Department of Hematology pays non établi dans la noticeUniversité ou école supérieure
Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca et Centro de Investigación del Cáncer, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.